Cornerstone Sues Exela Over Generic Hypertension Drug
By Drew Singer ( July 24, 2013, 4:41 PM EDT) -- Cornerstone Therapeutics Inc. on Wednesday told a Delaware federal judge that Exela Pharma Sciences LLC infringed two of its patents when it asked the FDA to approve a generic version of its hypertension drug before the original patent expired....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.